Rapid determination of designer benzodiazepines, benzodiazepines, and Z-hypnotics in whole blood using parallel artificial liquid membrane extraction and UHPLC-MS/MS
Benzodiazepines (BZD) and Z-hypnotics are frequently analyzed in forensic laboratories, and in 2012, the designer benzodiazepines (DBZD) emerged on the illegal drug scene. DBZD represent a particular challenge demanding new analytical methods. In this work, parallel artificial liquid membrane extraction (PALME) is used for sample preparation of DBZD, BZD, and Z-hypnotics in whole blood prior to UHPLC-MS/MS analysis. PALME of BZD, DBZD, and Z-hypnotics was performed from whole blood samples, and the analytes were extracted across a supported liquid membrane (SLM) and into an acceptor solution of dimethyl sulfoxide and 200 mM formic acid (75:25, v/v). The method was validated according to EMA guidelines. The method was linear throughout the calibration range (R2 > 0.99). Intra- and inter-day accuracy and precision, as well as matrix effects, were within the guideline limit of ± 15%. LOD and LLOQ ranged from 0.10 to 5.0 ng mL−1 and 3.2 to 160 ng mL−1, respectively. Extraction recoveries were reproducible and above 52%. The method was specific, and the analytes were stable in the PALME extracts for 4 and 10 days at 10 and − 20 °C. No carry-over was observed within the calibration range. PALME and UHPLC-MS/MS for the determination of DBZD, BZD, and Z-hypnotics in whole blood are a green and low-cost alternative that provides high sample throughput (96-well format), extensive sample clean-up, good sensitivity, and high reproducibility. The presented method is also the first method incorporating analysis of DBZD, BZD, and Z-hypnotics in whole blood in one efficient analysis.
KeywordsDesigner benzodiazepines Benzodiazepines Z-hypnotics Parallel artificial liquid membrane extraction LC-MS/MS Whole blood samples
The Research Council of Norway is acknowledged for financial support through grant no. 231917. Gerrit Middelkoop, Elianne Seeberg, Marit Langødegaard, and Elin Eliassen are gratefully acknowledged for their help with the method comparison.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 2.Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: a review. Drug Test Anal. 2017Google Scholar
- 5.Švidrnoch M, Boráňová B, Tomková J, Ondra P, Maier V. Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis–tandem mass spectrometry with successive multiple ionic–polymer layer coated capillary. Talanta. 2018;176:69–76.CrossRefPubMedGoogle Scholar
- 7.EMCDDA. European Drug Report 2017: Trends and Developments. 2017. http://www.emcdda.europa.eu/publications/edr/trends-developments/2017. Accessed 05.12.17.
- 10.Middelkoop G. Oslo University Hospital, personal communication 2017.Google Scholar
- 14.de Bairros AV, de Almeida RM, Pantaleão L, Barcellos T, e Silva SM, Yonamine M. Determination of low levels of benzodiazepines and their metabolites in urine by hollow-fiber liquid-phase microextraction (LPME) and gas chromatography–mass spectrometry (GC–MS). J Chromatogr B. 2015;975:24–33.CrossRefGoogle Scholar
- 15.De Boeck M, Dehaen W, Tytgat J, Cuypers E. Ionic liquid-based liquid–liquid microextraction for benzodiazepine analysis in postmortem blood samples. J Forensic Sci. 2018;Google Scholar
- 16.De Boeck M, Missotten S, Dehaen W, Tytgat J, Cuypers E. Development and validation of a fast ionic liquid-based dispersive liquid–liquid microextraction procedure combined with LC–MS/MS analysis for the quantification of benzodiazepines and benzodiazepine-like hypnotics in whole blood. Forensic Sci Int. 2017;274:44–54.CrossRefPubMedGoogle Scholar
- 17.Fisichella M, Odoardi S, Strano-Rossi S. High-throughput dispersive liquid/liquid microextraction (DLLME) method for the rapid determination of drugs of abuse, benzodiazepines and other psychotropic medications in blood samples by liquid chromatography–tandem mass spectrometry (LC-MS/MS) and application to forensic cases. Microchem J. 2015;123:33–41.CrossRefGoogle Scholar
- 22.Sanches LR, Seulin SC, Leyton V, Bismara Paranhos BAP, Pasqualucci CA, Munoz DR, et al. Determination of opiates in whole blood and vitreous humor: a study of the matrix effect and an experimental design to optimize conditions for the enzymatic hydrolysis of glucuronides. J Anal Toxicol. 2012;36(3):162–70.CrossRefPubMedGoogle Scholar
- 23.Berg T, Karlsen M, Øiestad ÅML, Johansen JE, Liu H, Strand DH. Evaluation of 13C-and 2H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography–tandem mass spectrometry. J Chromatogr A. 2014;1344:83–90.CrossRefPubMedGoogle Scholar
- 24.EMA. Guideline on bioanalytical method validation. 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf. Accessed 26.04.18.
- 25.GTFCH. Requirements for the validation of Anal Methods (Appendix B). 2009. https://www.gtfch.org/cms/images/stories/files/Appendix%20B%20GTFCh%2020090601.pdf. Accessed 26.04.18.
- 28.Strand DH, Langødegård M, Gaare KI, Amundsen I, Nilsen M, Kristoffersen L. Determination of twelve commonly found compounds in DUI cases in whole blood using fully automated supported liquid extraction and UHPLC-MS/MS. SOFT-TIAFT, Boca Raton, Florida, USA2018.Google Scholar
- 32.Verplaetse R, Cuypers E, Tytgat J. The evaluation of the applicability of a high pH mobile phase in ultrahigh performance liquid chromatography tandem mass spectrometry analysis of benzodiazepines and benzodiazepine-like hypnotics in urine and blood. J Chromatogr A. 2012;1249:147–54.CrossRefPubMedGoogle Scholar
- 33.Simonsen KW, Hermansson S, Steentoft A, Linnet K. A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction and ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2010;34(6):332–41.CrossRefPubMedGoogle Scholar